Aspirin resistance in the acute stages of acute ischemic stroke is associated with the development of new ischemic lesions.

Aspirin is a primary antiplatelet agent for the secondary prevention of ischemic stroke. However, if aspirin fails to inhibit platelet function, as is expected in acute ischemic stroke (AIS), it may increase the rate of early clinical events. Therefore, we sought to determine whether aspirin resista...

Full description

Bibliographic Details
Main Authors: Joon-Tae Kim, Suk-Hee Heo, Ji Sung Lee, Min-Ji Choi, Kang-Ho Choi, Tai-Seung Nam, Seung-Han Lee, Man-Seok Park, Byeong C Kim, Myeong-Kyu Kim, Ki-Hyun Cho
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4388531?pdf=render